Freedom of Science – Can Industry Influence What Scientists Publish?
European Endocrinology, 2014;10(1):10–3
Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 Diabetes
European Endocrinology, 2014;10(2):117–23
Ramesh Ramanathan, M.D., oncologist at Mayo Clinic in Arizona, and Anita Moyer, R.N., gastroenterology oncology nurse coordinator, explain how Mayo Clinic offers a seamless experience for patients...
Dr. Iftikhar Kullo, a consultant in the Division of Cardiovascular Diseases, Mayo Clinics’ Gonda Vascular Center, and Professor of Medicine for Mayo Clinic College of Medicine, explains his article...
Prof Schlumberger talks to ecancertv at ASCO 2014 about the results of the phase three SELECT trial, which was a multicentre, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients...